Related Experiment Video
Updated: Aug 30, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
[Study of adhesion-related molecule beta1-integrin and focal adhesion kinase in chronic myeloid leukemia]
Xuan Chang1, Xiao-li Liu, Qing-feng Du
1Department of Hematology, Nanfang Hospital, First Military Medical University, Guangzhou 510515, China.
Objective:
To study the changes in the expressions of beta1-integrin receptor (CD29) and focal adhesion kinase (FAK) during the deterioration of chronic myeloid leukemia (CML), thereby explore the potential mechanism of interferon (IFN)-alpha in the treatment of CML through testing the quantitative changes of FAK.
Methods:
Bone marrow mononuclear cells were tested for CD34, CD29 and FAK monoclonal antibody by flow cytometry in CML patients of the chronic phase and blast crisis and in normal subjects. In the presence or absence of IFN-alpha, the bone marrow mononuclear cells from CML patients of chronic phase and normal subjects were cultured for 48 h to determine the content of FAK in the cells with Western blotting.
Results:
CD 29 expression on the surface of CD34+ cells scarcely differ between normal subjects and CML patients of chronic-phase, but the intracellular content of FAK was lower in the latter. The expression of beta1-integrin receptor on the surface of hematopoietic cells in CML patients with blast crisis was significantly higher than that in chronic-phase CML patients, but the intracellular FAK in the former patients was lower. No difference of FAK content was observed in normal mononuclear cells before and after IFN-alpha treatment, while the treatment increased FAK content in the mononuclear cells in chronic phase CML patients.
Conclusion:
The changes in the expressions of beta1-integrin receptor and FAK may play important roles during CML deterioration, and IFN-alpha may function to repair the defect in the beta1-integrin receptor pathway by restoring the cellular content of FAK.
Insights
Changes in beta1-integrin receptor (CD29) and focal adhesion kinase (FAK) are linked to chronic myeloid leukemia (CML) progression. Interferon-alpha (IFN-alpha) may treat CML by restoring FAK levels.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Research
Background:
- Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the Philadelphia chromosome.
- Integrin receptors and focal adhesion kinase (FAK) play critical roles in cell adhesion, migration, and survival.
- Understanding the role of these molecules in CML pathogenesis is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the alterations in beta1-integrin receptor (CD29) and FAK expression during CML progression.
- To elucidate the potential mechanism of interferon-alpha (IFN-alpha) in CML treatment by examining its effect on FAK levels.
Main Methods:
- Flow cytometry was used to quantify CD34, CD29, and FAK expression on bone marrow mononuclear cells from CML patients (chronic phase and blast crisis) and healthy controls.
- Western blotting was employed to determine intracellular FAK content in cultured cells with or without IFN-alpha treatment.
Main Results:
- CD29 expression showed minimal difference between normal subjects and chronic-phase CML patients, but intracellular FAK was lower in CML patients.
- Blast crisis CML patients exhibited significantly higher surface beta1-integrin receptor expression but lower intracellular FAK compared to chronic-phase patients.
- IFN-alpha treatment increased FAK content in chronic-phase CML cells, but not in normal cells.
Conclusions:
- Aberrant expression of beta1-integrin receptor and FAK is implicated in CML deterioration.
- IFN-alpha may exert its therapeutic effect in CML by rectifying the beta1-integrin receptor pathway through FAK restoration.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Selectins

